PROM1 and glioma: Importantly, simultaneous activation of HH pathway and inhibition of thymidine de novo synthesis pathway showed a synergistic effect on [I-125]ITdU incorporation in glioma cells (63.2%±2.3% and 42.8%±2.1% in CD133+ and CD133− cells, respectively).